I am a
Home I AM A Search Login

Papers of the Week


2022


BMJ Neurol Open


4


2

Efficacy of botulinum toxin type a in the targeted treatment of sleep bruxism: a double-blind, randomised, placebo-controlled, cross-over study.

Authors

Cruse B, Dharmadasa T, White E, Hollis C, Evans A, Sharmin S, Kalincik T, Kiers L
BMJ Neurol Open. 2022; 4(2):e000328.
PMID: 36110927.

Abstract

Intramuscular injections of botulinum toxin A (BTX-A) have been used in the treatment of sleep bruxism (SB) however controlled trials are limited and the optimal injection strategy and dose is not known.